216 related articles for article (PubMed ID: 37762600)
61. Hsa-miR-425-5p promotes tumor growth and metastasis by activating the CTNND1-mediated β-catenin pathway and EMT in colorectal cancer.
Liu D; Zhang H; Cui M; Chen C; Feng Y
Cell Cycle; 2020 Aug; 19(15):1917-1927. PubMed ID: 32594834
[TBL] [Abstract][Full Text] [Related]
62. Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3.
Toda H; Kurozumi S; Kijima Y; Idichi T; Shinden Y; Yamada Y; Arai T; Maemura K; Fujii T; Horiguchi J; Natsugoe S; Seki N
J Hum Genet; 2018 Dec; 63(12):1197-1210. PubMed ID: 30228364
[TBL] [Abstract][Full Text] [Related]
63. Integrative Bioinformatics Analysis Reveals That miR-524-5p/MEF2C Regulates Bone Metastasis in Prostate Cancer and Breast Cancer.
Tian Q; Lu Y; Yan B; Wu C
Comput Math Methods Med; 2022; 2022():5211329. PubMed ID: 36128051
[TBL] [Abstract][Full Text] [Related]
64. Long non-coding RNA SNHG8 enhances triple-negative breast cancer cell proliferation and migration by regulating the miR-335-5p/PYGO2 axis.
Qian J; Lei X; Sun Y; Zheng L; Li J; Zhang S; Zhang L; Li W; Shi J; Jia W; Tang T
Biol Direct; 2021 Aug; 16(1):13. PubMed ID: 34362407
[TBL] [Abstract][Full Text] [Related]
65. MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells.
Chung YH; Li SC; Kao YH; Luo HL; Cheng YT; Lin PR; Tai MH; Chiang PH
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829370
[TBL] [Abstract][Full Text] [Related]
66. MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition.
Guan X; Gu S; Yuan M; Zheng X; Wu J
Oncol Lett; 2019 Dec; 18(6):5986-5994. PubMed ID: 31788073
[TBL] [Abstract][Full Text] [Related]
67. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
[TBL] [Abstract][Full Text] [Related]
68. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1.
Selem NA; Nafae H; Manie T; Youness RA; Gad MZ
Pathol Res Pract; 2023 Aug; 248():154579. PubMed ID: 37301086
[TBL] [Abstract][Full Text] [Related]
69. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.
Wang Q; Cheng Y; Wang Y; Fan Y; Li C; Zhang Y; Wang Y; Dong Q; Ma Y; Teng YE; Qu X; Liu Y
BMC Cancer; 2017 Jul; 17(1):492. PubMed ID: 28724364
[TBL] [Abstract][Full Text] [Related]
70. Hsa-miR-497-3p impedes the proliferation and invasion of triple-negative breast cancer cells by controlling epithelial-mesenchymal transition through ZEB1 targeting.
Dong Q; Chen H; Li Y; Kong Y; Geng C; Liu Y
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):78-83. PubMed ID: 37715420
[TBL] [Abstract][Full Text] [Related]
71. Cyanidin-3-glucoside induces mesenchymal to epithelial transition via activating Sirt1 expression in triple negative breast cancer cells.
Liang L; Liu X; He J; Shao Y; Liu J; Wang Z; Xia L; Han T; Wu P
Biochimie; 2019 Jul; 162():107-115. PubMed ID: 30876970
[TBL] [Abstract][Full Text] [Related]
72. LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702.
Mou E; Wang H
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31399501
[TBL] [Abstract][Full Text] [Related]
73. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.
Fan Y; Wang J; Jin W; Sun Y; Xu Y; Wang Y; Liang X; Su D
Mol Cancer; 2021 Feb; 20(1):25. PubMed ID: 33530981
[TBL] [Abstract][Full Text] [Related]
74. MEF2C-AS1 regulates its nearby gene MEF2C to mediate cervical cancer cell malignant phenotypes in vitro.
Guo Q; Zhang L; Zhao L; Pang X; Wang P; Sun H; Liu S
Biochem Biophys Res Commun; 2022 Dec; 632():48-54. PubMed ID: 36198203
[TBL] [Abstract][Full Text] [Related]
75. Screening of acetaminophen-induced alterations in epithelial-to-mesenchymal transition-related expression of microRNAs in a model of stem-like triple-negative breast cancer cells: The possible functional impacts.
Afshar E; Hashemi-Arabi M; Salami S; Peirouvi T; Pouriran R
Gene; 2019 Jun; 702():46-55. PubMed ID: 30898700
[TBL] [Abstract][Full Text] [Related]
76. MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Schwarzenbacher D; Klec C; Pasculli B; Cerk S; Rinner B; Karbiener M; Ivan C; Barbano R; Ling H; Wulf-Goldenberg A; Stanzer S; Rinnerthaler G; Stoeger H; Bauernhofer T; Haybaeck J; Hoefler G; Jahn SW; Parrella P; Calin GA; Pichler M
Breast Cancer Res; 2019 Feb; 21(1):20. PubMed ID: 30709367
[TBL] [Abstract][Full Text] [Related]
77. PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer.
Song W; Tang L; Xu Y; Xu J; Zhang W; Xie H; Wang S; Guan X
Sci Rep; 2017 Feb; 7():42319. PubMed ID: 28176879
[TBL] [Abstract][Full Text] [Related]
78. A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis.
Hu Y; He Y; Luo N; Li X; Guo L; Zhang K
Cancer Biol Ther; 2023 Dec; 24(1):2235768. PubMed ID: 37548553
[TBL] [Abstract][Full Text] [Related]
79. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
Han C; Li X; Fan Q; Liu G; Yin J
Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
[TBL] [Abstract][Full Text] [Related]
80. CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple-negative breast cancer by targeting miR-761/DACT2 signaling axis.
Huang S; Xie J; Lei S; Fan P; Zhang C; Huang Z
Mol Carcinog; 2023 Apr; 62(4):450-463. PubMed ID: 36562476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]